These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32900513)
21. Exploring the Mystery of Angiotensin-Converting Enzyme II (ACE2) in the Battle against SARS-CoV-2. Sharma D; Sharma J; Singh A J Renin Angiotensin Aldosterone Syst; 2021; 2021():9939929. PubMed ID: 34285711 [TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2, ACE2 expression, and systemic organ invasion. Ashraf UM; Abokor AA; Edwards JM; Waigi EW; Royfman RS; Hasan SA; Smedlund KB; Hardy AMG; Chakravarti R; Koch LG Physiol Genomics; 2021 Feb; 53(2):51-60. PubMed ID: 33275540 [TBL] [Abstract][Full Text] [Related]
23. Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads. Hoevenaar M; Goossens D; Roorda J J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320979097. PubMed ID: 33283602 [TBL] [Abstract][Full Text] [Related]
24. Classical and alternative receptors for SARS-CoV-2 therapeutic strategy. Masre SF; Jufri NF; Ibrahim FW; Abdul Raub SH Rev Med Virol; 2021 Sep; 31(5):1-9. PubMed ID: 33368788 [TBL] [Abstract][Full Text] [Related]
25. Can beta-adrenergic blockers be used in the treatment of COVID-19? Vasanthakumar N Med Hypotheses; 2020 Sep; 142():109809. PubMed ID: 32388480 [No Abstract] [Full Text] [Related]
26. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). Cadegiani FA; Goren A; Wambier CG Med Hypotheses; 2020 Oct; 143():110112. PubMed ID: 32721806 [TBL] [Abstract][Full Text] [Related]
27. Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19. Shin J; Toyoda S; Nishitani S; Fukuhara A; Kita S; Otsuki M; Shimomura I Diabetes; 2021 Dec; 70(12):2745-2755. PubMed ID: 34615619 [TBL] [Abstract][Full Text] [Related]
28. The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections. Ferrara F; Vitiello A Naunyn Schmiedebergs Arch Pharmacol; 2021 Jul; 394(7):1589-1593. PubMed ID: 34151392 [TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells. Coate KC; Cha J; Shrestha S; Wang W; Gonçalves LM; Almaça J; Kapp ME; Fasolino M; Morgan A; Dai C; Saunders DC; Bottino R; Aramandla R; Jenkins R; Stein R; Kaestner KH; Vahedi G; ; Brissova M; Powers AC Cell Metab; 2020 Dec; 32(6):1028-1040.e4. PubMed ID: 33207245 [TBL] [Abstract][Full Text] [Related]
30. Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection? Haggag YA; El-Ashmawy NE; Okasha KM Med Hypotheses; 2020 Nov; 144():109957. PubMed ID: 32531538 [TBL] [Abstract][Full Text] [Related]
31. Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19. Kusmartseva I; Wu W; Syed F; Van Der Heide V; Jorgensen M; Joseph P; Tang X; Candelario-Jalil E; Yang C; Nick H; Harbert JL; Posgai AL; Paulsen JD; Lloyd R; Cechin S; Pugliese A; Campbell-Thompson M; Vander Heide RS; Evans-Molina C; Homann D; Atkinson MA Cell Metab; 2020 Dec; 32(6):1041-1051.e6. PubMed ID: 33207244 [TBL] [Abstract][Full Text] [Related]
32. Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement. Amirfakhryan H; Safari F Hellenic J Cardiol; 2021; 62(1):13-23. PubMed ID: 32522617 [TBL] [Abstract][Full Text] [Related]
33. Drugs acting on the renin-angiotensin system and SARS-CoV-2. Vitiello A; Pelliccia C; Ferrara F Drug Discov Today; 2021 Apr; 26(4):870-874. PubMed ID: 33486116 [TBL] [Abstract][Full Text] [Related]
34. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions. Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186 [TBL] [Abstract][Full Text] [Related]
35. How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17. Healy EF Biochem Biophys Res Commun; 2022 Feb; 593():52-56. PubMed ID: 35063769 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry. Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545 [TBL] [Abstract][Full Text] [Related]
37. Cardiology and COVID-19: do we have sufficient information? Garg N; McClafferty B; Ramgobin D; Golamari R; Jain R; Jain R Future Cardiol; 2021 Jul; 17(4):705-711. PubMed ID: 33124920 [TBL] [Abstract][Full Text] [Related]